Tetraphase Pharma (TTPH) Misses Q4 EPS by 6c

Tetraphase Pharma (NASDAQ: TTPH) reported Q4 EPS of ($0.50), $0.06 worse than the analyst estimate of ($0.44). Revenue for the quarter came in at $2.47 million versus the consensus estimate of $3.23 million.

For earnings history and earnings-related data on Tetraphase Pharma (TTPH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c